Upstate Active Clinical Trials

Study Title:

CALGB 50801-Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I And Stage II Classical Hodgkin Lymphoma (HL)

What is the purpose of the study?

This phase II clinical trial is studying how well response-based therapy assessed by PET scan works in treating patients with bulky stage I and stage II Hodgkin lymphoma.

Upstate Institutional Review Board (IRB) Number:

267123

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Teresa C Gentile, MD, PhD

ClinicalTrials.Gov ID:

NCT01118026

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Virginia M Schutt, CCRP
Phone: 315-464-8230
Email: schuttg@upstate.edu

Return to Previous Page || Search Again